Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

454.67 -5.92 (-1.29%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

69 70 Next >

Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years ↗

September 06, 2024

Via Benzinga

3 No-Brainer Stocks to Buy in September ↗

August 31, 2024

There's at least one key common denominator here: tremendous growth prospects.

Via The Motley Fool

3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever ↗

August 30, 2024

These three have secure core businesses, plus multiple paths to grow.

Via The Motley Fool

3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow ↗

August 30, 2024

Vertex should have a future full of bright tomorrows.

Via The Motley Fool

Vertex Pharmaceuticals's Options Frenzy: What You Need to Know ↗

August 29, 2024

Via Benzinga

Biotech And Life Science Sector Update Summer Of 2024 ↗

August 29, 2024

It’s the slowest week of the year, we are at the market top and most earnings reports are good.

Via Talk Markets

Looking Into Vertex Pharmaceuticals's Recent Short Interest ↗

August 27, 2024

Via Benzinga

Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals ↗

August 23, 2024

Via Benzinga

If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,900 Today ↗

August 21, 2024

Via Benzinga

Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics ↗

August 29, 2024

Jim Cramer discusses Serve Robotics, Builders FirstSource, Vertex Pharmaceuticals and Viking Therapeutics on CNBC.

Via Benzinga

Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead ↗

August 23, 2024

Vertex Pharmaceuticals has a lot going for it.

Via The Motley Fool

Vertex to Participate in Upcoming September Investor Conferences

August 22, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Biotech Bull Market: 3 Ways To Play It ↗

August 20, 2024

Although we are in the later stages of this bull market a cut in interest rates by the Fed should help biotech as you have seen from the recent rally.

Via Talk Markets

Topics Economy

Soviet Code Breaker Jim Simons' Hedge Fund Renaissance Technologies — Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings ↗

August 19, 2024

Renaissance Technologies, the hedge fund founded by legendary mathematician and former NSA code breaker Jim Simons, recently disclosed its latest stock holdings in a 13F filing with the U.S. Securities...

Via Benzinga

Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals ↗

August 09, 2024

Via Benzinga

These 2 Incredible Growth Stocks Are Set to Soar This Summer and Beyond ↗

August 18, 2024

It's always a good time to invest cash in quality businesses.

Via The Motley Fool

3 Fantastic Growth Stocks to Buy in August ↗

August 17, 2024

These stocks should keep up their winning ways.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 15, 2024

Via Benzinga

3 Biotech Stocks to Buy on the Dip: August 2024 ↗

August 15, 2024

These are three of the best biotech stocks to buy on the dip due to their strong fundamentals and market positioning.

Via InvestorPlace

Prediction: These 4 Future Technologies Will Be Millionaire-Makers -- and Here Are the Top Stocks to Buy Now to Profit From Them ↗

August 15, 2024

These technologies could be game-changers. And they could make forward-thinking investors a lot of money.

Via The Motley Fool

2 Biotech Stocks to Buy Hand Over Fist in August ↗

August 12, 2024

Both of these biotechs are highly innovative companies.

Via The Motley Fool

The 3 Best Biotech Stocks to Buy in August 2024 ↗

August 08, 2024

These biotech stocks are leading the way with groundbreaking therapies and robust fundamentals offering superb upside ahead.

Via InvestorPlace

Vertex Announces CASGEVY™ Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia in England

August 07, 2024

From Vertex Pharmaceuticals

Via Business Wire

Is It Too Late to Buy Vertex Pharmaceuticals Stock? ↗

August 06, 2024

Shares of the rare disease drugmaker are already up more than 40% over the past year.

Via The Motley Fool

Prediction: These Could Be the Best-Performing Growth Stocks Through 2030 ↗

August 05, 2024

Great companies are found in every type of market landscape.

Via The Motley Fool

3 Biotech Stocks on Track for 50% Returns (or More) by 2028 ↗

August 04, 2024

Investors should consider snapping up these high potential biotech stocks that could return 50% or more by 2028!

Via InvestorPlace

Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker ↗

August 04, 2024

The biotech recently became a commercial-stage company.

Via The Motley Fool

3 Unstoppable Stocks to Buy in August ↗

August 03, 2024

It's not hard to envision how all three of these stocks can deliver exceptional growth.

Via The Motley Fool

Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now ↗

August 03, 2024

These two healthcare companies have far more upside potential than Johnson & Johnson.

Via The Motley Fool

3 Biotech Stocks That Could Have Investors Grinning Soon ↗

August 02, 2024

Biotech stocks are a high risk, high reward investment and these three biotechs offer significant upside potential.

Via InvestorPlace

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

69 70 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.